This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

COVID-19 Diagnostics Dashboard

By Diagnostics

An interactive tool to support product selection and procurement decisions by aggregating and visualizing publicly available information about the development, supply, regulatory approvals, and performance of COVID-19 diagnostic tests

Large-scale testing and contact tracing are central to efforts to control the COVID-19 pandemic. This relies on diagnostic tests that can rapidly, accurately, and reliably detect SARS-CoV-2. However, with over 1,000 COVID diagnostics tests currently in development or on the market, understanding test quality, performance and availability at the global and country level is extremely challenging.

Explore the COVID-19 Diagnostics Dashboard

About this resource

A multidisciplinary team at PATH has developed the interactive COVID-19 Diagnostics Dashboard which consolidates publicly available market intelligence to support data-driven procurement and purchasing decisions. This tool is designed to be used by national governments, procurers, funders, and policymakers.

Diagnostics can be searched by diagnostic platform, test performance, regulatory status, country of origin, and commercial availability.

The data will be refreshed biweekly until the end of 2020. PATH is seeking funding to keep the data current through 2021 and add additional features. If you would like to fund this initiative to ensure its continuity, please email dxcovid@path.org.

If you would like to be alerted when updates are made, or future features are added, please email dxcovid@path.org with your contact details.

Read More